Axogen Directors Engage in Multiple Stock Transactions
| Reporter Name | Relationship | Type | Amount | SEC Filing |
|---|---|---|---|---|
| Tyndall Joseph A. | Director | Sell | $288,700 | Form 4 |
| Johnson John | Director | Sell | $43,214 | Form 4 |
| Neels Guido J | Director | Sell | $43,214 | Form 4 |
| Burke William P. Mr. | Director | Sell | $43,214 | Form 4 |
| Wendell Amy Mcbride | Director | Sell | $43,214 | Form 4 |
| Levine Alan M | Director | Sell | $43,214 | Form 4 |
| Weiler Kathy Johnson | Director | Sell | $43,214 | Form 4 |
Joseph A. Tyndall, a Director at Axogen, sold 26,931 shares of Common Stock on June 10, 2025, for a total sale amount of $288,700, at a weighted average price of $10.72 per share. Following this transaction, Tyndall no longer directly owns any Common Stock in Axogen.
John Johnson, a Director at Axogen, sold 4,073 shares of Common Stock on June 9, 2025, at a weighted average price of $10.61 per share, totaling $43,214. Following the transaction, Johnson directly owns 24,943 shares of Axogen.
Guido J Neels, a Director at Axogen, sold 4,073 shares of Common Stock on June 9, 2025, at a weighted average price of $10.61 per share, totaling $43,214. Following the transaction, Neels directly owns 86,743 shares of Axogen.
William P. Burke, a Director at Axogen, sold 4,073 shares of Common Stock on June 9, 2025, at a weighted average price of $10.61 per share, totaling $43,214. Following the transaction, Burke directly owns 24,484 shares of Axogen.
Wendell Amy McBride, a Director at Axogen, sold 4,073 shares of Common Stock on June 9, 2025, at a weighted average price of $10.61 per share, totaling $43,214. Following the transaction, McBride directly owns 93,826 shares of Axogen.
Alan M Levine, a Director at Axogen, sold 4,073 shares of Common Stock on June 9, 2025, at a weighted average price of $10.61 per share, totaling $43,214. Following the transaction, Levine directly owns 36,743 shares of Axogen.
Kathy Johnson, a Director at Axogen, sold 4,073 shares of Common Stock on June 9, 2025, at a weighted average price of $10.61 per share, totaling $43,214. Following the transaction, Johnson directly owns 6,580 shares of Axogen.